Cancer Registry Software Market to Reach USD 200.6 Million by 2034

Pune, India, November 7, 2025 - The Global Cancer Registry Software Market is projected to grow from USD 110.2 million in 2024 to approximately USD 200.6 million by 2034, registering a CAGR of 6.1% during the forecast period (2025-2034), according to Exactitude Consultancy. This growth is driven by the increasing prevalence of cancer worldwide, expanding implementation of national cancer surveillance programs, and the rapid adoption of electronic health record (EHR)-integrated registry software across hospitals and research centers.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49092

Key Takeaways
• Market Size (2024): USD 110.2 Million
• Forecast (2034): USD 200.6 Million
• CAGR (2025-2034): 6.1%
• Key Segments: Type, Database Type, Deployment, End User, and Region
• Leading Companies: Elekta AB, McKesson Corporation, Oracle Cerner Corporation, IBM Watson Health, C/Net Solutions, Rocky Mountain Cancer Data Systems, Onco Inc., and MIM Software Inc.

Market Story
Cancer registry software plays a crucial role in collecting, managing, and analyzing cancer-related data for public health planning, clinical decision-making, and research. With over 19 million new cancer cases reported globally each year, the need for integrated, accurate, and scalable data management solutions has never been greater.

Modern registry platforms go beyond basic data collection - they now integrate AI analytics, cloud-based storage, and interoperability with EHR systems to support predictive modeling and real-world evidence (RWE) generation. Governments and healthcare organizations are increasingly investing in digital cancer registries to track incidence, mortality, and treatment outcomes, enhancing both national and regional cancer control programs.

Furthermore, the integration of machine learning (ML) algorithms and natural language processing (NLP) enables real-time patient data updates and automated case abstraction from clinical records, reducing manual effort and improving data accuracy.

Market Segmentation
By Type:
Standalone Software, Integrated Software

By Database Type:
Hospital-Based Registries, Population-Based Registries, Specialty-Based Registries

By Deployment:
On-Premise, Cloud-Based

By End User:
Hospitals & Clinics, Research Institutes, Government Organizations, Public Health Agencies

By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49092/cancer-registry-software-market

Recent Developments
• Elekta AB expanded its oncology data management solutions with integrated cloud-based cancer registry platforms.
• Oracle Cerner launched PowerChart Oncology Suite, enhancing interoperability and RWE analytics for cancer treatment monitoring.
• IBM Watson Health partnered with research institutions to develop AI-assisted cancer surveillance and predictive outcome models.
• C/Net Solutions introduced next-gen Abstract Plus 2.0 to automate data collection across multiple oncology sites.
• Rocky Mountain Cancer Data Systems upgraded SEER registry tools to meet evolving national data standards and improve visualization.

Expert Insight
"The integration of AI, cloud computing, and EHR interoperability has revolutionized cancer registries. Modern systems now enable predictive insights, streamline case reporting, and support precision oncology research globally,"
- Lead Healthcare IT Analyst, Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49092

Market Drivers
• Rising Cancer Prevalence: Growing need for accurate incidence and survival tracking.
• Digital Transformation in Healthcare: Increased use of cloud-based and AI-powered data platforms.
• Government Initiatives: National cancer surveillance and research funding boosting adoption.
• Regulatory Mandates: Global emphasis on data accuracy and interoperability in oncology reporting.

Forecast & Regional Insights
North America dominates the global cancer registry software market, accounting for over 45% of total revenue in 2024, owing to established cancer surveillance infrastructure (e.g., SEER and NAACCR) and government-backed initiatives. Europe follows, driven by cross-border oncology data-sharing programs under the EU's European Cancer Plan. The Asia-Pacific region is expected to register the fastest CAGR of 7.2%, propelled by healthcare digitization, increasing cancer burden, and public health data modernization efforts across India, China, and Japan.

Conclusion
The cancer registry software market is entering a data-driven era where AI, cloud integration, and automation are redefining how cancer information is captured, analyzed, and shared. With healthcare systems prioritizing real-world data accuracy and cross-institutional collaboration, the next decade will see registry software evolve into a core component of global oncology management and research.

This report is also available in the following languages : Japanese (がん登録ソフトウェア市場), Korean (암 등록 소프트웨어 시장), Chinese (癌症登记软件市场), French (Marché des logiciels de registre du cancer), German (Markt für Software zur Krebsregisterführung), and Italian (Mercato del software per i registri dei tumori), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49092/cancer-registry-software-market#request-a-sample

Related Reports

Personalized Medicines In Oncology Market
https://exactitudeconsultancy.com/reports/75561/personalized-medicines-in-oncology-market

Fecal Occult Testing Market
https://exactitudeconsultancy.com/reports/75739/fecal-occult-testing-market

Patient-Derived Xenograft Model Market
https://exactitudeconsultancy.com/reports/75748/patient-derived-xenograft-model-market

Kinase Inhibitors Market
https://exactitudeconsultancy.com/reports/75814/kinase-inhibitors-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.